700 related articles for article (PubMed ID: 16052839)
21. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
Laurino S; Borrelli S; Catapano F; Mascia S; D'Angio' P; Calabria M; Grimaldi M; Salvio A; Minutolo R; De Nicola L; Conte G
G Ital Nefrol; 2009; 26(3):318-27. PubMed ID: 19554529
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus-related heat-insoluble cryoglobulinemia and thrombotic microangiopathy.
Wu H; Zou HB; Xu Y; Zhang L; Du YJ; Yu JY; Lu RH; Li X
Am J Med Sci; 2013 Oct; 346(4):345-8. PubMed ID: 23744520
[TBL] [Abstract][Full Text] [Related]
23. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
Alric L; Plaisier E; Thébault S; Péron JM; Rostaing L; Pourrat J; Ronco P; Piette JC; Cacoub P
Am J Kidney Dis; 2004 Apr; 43(4):617-23. PubMed ID: 15042538
[TBL] [Abstract][Full Text] [Related]
24. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy.
Namba T; Shiba R; Yamamoto T; Hirai Y; Moriwaki T; Matsuda J; Kadoya H; Takeji M; Yamada Y; Yoshihara H; Yamauchi A
Clin Exp Nephrol; 2010 Aug; 14(4):372-6. PubMed ID: 20467773
[TBL] [Abstract][Full Text] [Related]
26. Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4.
Elmowafy AY; El Maghrabi HM; Zahab MA; Elwasif SM; Bakr MA
Iran J Kidney Dis; 2018 Nov; 12(6):382-384. PubMed ID: 30595569
[TBL] [Abstract][Full Text] [Related]
27. New insights in cryoglobulinemic vasculitis.
Silva F; Pinto C; Barbosa A; Borges T; Dias C; Almeida J
J Autoimmun; 2019 Dec; 105():102313. PubMed ID: 31383568
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin.
Del Bello A; Guilbeau-Frugier C; Josse AG; Rostaing L; Izopet J; Kamar N
Transpl Infect Dis; 2015 Apr; 17(2):279-83. PubMed ID: 25708383
[TBL] [Abstract][Full Text] [Related]
29. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
30. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.
Saadoun D; Resche-Rigon M; Thibault V; Piette JC; Cacoub P
Arthritis Rheum; 2006 Nov; 54(11):3696-706. PubMed ID: 17075881
[TBL] [Abstract][Full Text] [Related]
31. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.
Fabrizi F; Lunghi G; Messa P; Martin P
J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865
[TBL] [Abstract][Full Text] [Related]
32. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Benstead TJ; Chalk CH; Parks NE
Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy.
Morales JM; Kamar N; Rostaing L
Contrib Nephrol; 2012; 176():10-23. PubMed ID: 22310777
[TBL] [Abstract][Full Text] [Related]
34. Cryoglobulinemic membranoproliferative glomerulonephritis: beyond conventional therapy.
Colucci G; Manno C; Grandaliano G; Schena FP
Clin Nephrol; 2011 Apr; 75(4):374-9. PubMed ID: 21426893
[TBL] [Abstract][Full Text] [Related]
35. A case of multiple extrahepatic manifestations in a patient with untreated, chronic hepatitis C virus infection.
Meillier A; McGee J; Kartan S; Baskin S
Int J Infect Dis; 2014 Feb; 19():93-4. PubMed ID: 24315985
[TBL] [Abstract][Full Text] [Related]
36. [Hepatitis-C-virus-associated cryoglobulinemia. Pathogenesis, diagnosis and treatment].
Staak JO; Glossmann JP; Diehl V; Josting A
Med Klin (Munich); 2002 Oct; 97(10):601-8. PubMed ID: 12386793
[TBL] [Abstract][Full Text] [Related]
37. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.
Sise ME; Bloom AK; Wisocky J; Lin MV; Gustafson JL; Lundquist AL; Steele D; Thiim M; Williams WW; Hashemi N; Kim AY; Thadhani R; Chung RT
Hepatology; 2016 Feb; 63(2):408-17. PubMed ID: 26474537
[TBL] [Abstract][Full Text] [Related]
38. Rheumatologic manifestations of Hepatitis C Virus.
Treppo E; Quartuccio L; Ragab G; DE Vita S
Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
[TBL] [Abstract][Full Text] [Related]
39. Cryoglobulinemia-related vasculitis during effective anti-HCV treatment with PEG-interferon alfa-2b.
De Blasi T; Aguilar Marucco D; Cariti G; Maiello A; De Rosa FG; Di Perri G
Infection; 2008 Jun; 36(3):285-7. PubMed ID: 17962905
[TBL] [Abstract][Full Text] [Related]
40. Role of ribavirin in membranoproliferative glomerulonephritis associated with hepatitis C virus infection refractory to alpha-interferon.
Pérez-Calvo J; Lasierra P; Moros M; Iñigo P
Nephron; 2002 Oct; 92(2):459-62. PubMed ID: 12218331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]